A detailed history of Culbertson A N & CO Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Culbertson A N & CO Inc holds 753 shares of LLY stock, worth $562,581. This represents 0.1% of its overall portfolio holdings.

Number of Shares
753
Previous 312 141.35%
Holding current value
$562,581
Previous $240,000 158.75%
% of portfolio
0.1%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$725.72 - $929.72 $320,042 - $410,006
441 Added 141.35%
753 $621,000
Q4 2024

Jan 16, 2025

SELL
$727.2 - $932.06 $52,358 - $67,108
-72 Reduced 18.75%
312 $240,000
Q3 2024

Oct 16, 2024

SELL
$772.14 - $960.02 $3,860 - $4,800
-5 Reduced 1.29%
384 $340,000
Q2 2024

Jul 30, 2024

SELL
$724.87 - $909.04 $10,148 - $12,726
-14 Reduced 3.47%
389 $352,000
Q3 2023

Oct 18, 2023

BUY
$434.7 - $599.3 $175,184 - $241,517
403 New
403 $216,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $710B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Culbertson A N & CO Inc Portfolio

Follow Culbertson A N & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Culbertson A N & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Culbertson A N & CO Inc with notifications on news.